Aerin Medical
Developer of therapeutic devices to improve nasal breathing
📍 Sunnyvale, United States · Pulmonology
Funding snapshot
Last roundSeries E
Amount$32M
Date13 December 2024
About
Developer of therapeutic devices to improve nasal breathing. It offers VivAer and RhinAer non‑invasive treatments that deliver tissue-sparing, temperature-controlled radiofrequency for nasal airway obstruction and chronic rhinitis.
Latest news
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer
ImmunoACT
Developer of cell and gene therapies for cancer treatment
HaystackAnalytics
Provider of genomics technology for personalized clinical decisions
4baseCare
Provider of precision oncology solutions, including genomic testing and digital health